Results 81 to 90 of about 1,073 (146)

Evolution des volumes musculaires orbitaires sous traitement par protocole EUGOGO dans l'orbitopathie basedowienne active

Objectif : évaluer l’impact du protocole EUGOGO sur le volume musculaire orbitaire dans l’orbitopathie basedowienne modérée à sévère active. Méthode : il s’agit d’une étude observationnelle, monocentrique, rétrospective, incluant 20 patients soit 40 ...
Aubeleau, Mathilde
core  

Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism

, 2018
OBJECTIVE : To construct a predictive score for the development or progression of Graves’ orbitopathy (GO) in Graves’ hyperthyroidism (GH). DESIGN : Prospective observational study in patients with newly diagnosed GH, treated with antithyroid drugs (ATD)
Kahaly, George, Luigi Bartalena, Christina Burlacu, M., Daumerie, C., Pitz, S., Brix, Thomas Heiberg, Knuk O, Burlacu, Maria-Christina, George Kahaly, Okosieme, O., Mario Salvi, Wiersinga, W., Hegedös, L., Perros, P., Hegedus L, Goksun Ayvaz, Fichter, Nicole, Danila Covelli, Georg von Arx, Töröner, F.B., Bartalena L, Morris, D., TÖRÜNER, FÜSUN SAADET, Bartalena, Luigi, Lareida, J., Donati, S., Morris, Daniel, Toruner FB, Jurg Lareida, Lareida, Juerg, Onur Konuk, Onyebuchi Okosieme, Pitz S, Daniel Morris, Covelli D, Burlacu, Maria Cristina, Ayvaz, Goksun, Daumerie, Chantal, Beleslin, B., Ćirić, J., Salvi, Mario, Covelli, Danila, Kahaly, George J, Hegedüs, Laszlo, Simone Donati, Donati, Simone, Bartalena, L., Wiersinga, Wilmar M, Okosieme O, Currò N, Konuk, O., Salvi M, Wiersinga, Wilmar, Fichter, N., Arx, G.V., Daumerie C, Ciric J, Žarković, Miloš, Brix, T., Biljana Beleslin, Wiersinga W, Perros P, Brix, Thomas, Balos Toruner, Fusun, Ayvaz G, Fichter N, Beleslin, Biljana, Nicole Fichter, Füsun Balos̜ Törüner, Ayvaz, G., Lareida J, Susanne Pitz, Konuk, Onur, Zarkovic M, Lareida, Jurg, Salvi, M., Burlacu MG, Okosieme, Onyebuchi, Žarković, M., Petros Perros, Pitz, Susanne, Kahaly, G., Nicola Curro, von Arx, Georg, Thomas Brix, Ćirić, Jasmina, Currò, Nicola, Kahaly G, Laszlo Hegedüs, Brix T and EUGOGO (European Group on Graves' Orbitopathy), von Arx G, Morris D, Miloš Žarković, Beleslin B, _ _, Jasmina Ćirić, Donati S, Curro, N., Chantal Daumerie, Perros, Petros, Covelli, D., Wilmar Wiersinga, Maria-Christina Burlacu, Wiersinga, Wilmar and Zarkovic, Milos and Bartalena, Luigi and Donati, Simone and Perros, Petros and Okosieme, Onyebuchi and Morris, Daniel and Fichter, Nicole and Lareida, Jurg and von Arx, Georg and Daumerie, Chantal and Burlacu, Maria-Christina and Kahaly, George and Pitz, Susanne and Beleslin, Biljana and Ciric, Jasmina and Ayvaz, Goksun and Konuk, Onur and Toruner, Fusun Balos and Salvi, Mario and Covelli, Danila and Curro, Nicola and Hegedus, Laszlo and Brix, Thomas   +103 more
core   +1 more source

Real world effectiveness of Mycophenolate-sodium therapy in patients at risk with Graves’ orbitopathy

Thyroid Research
Purpose Patients with active, moderate-to-severe Graves’ orbitopathy require immunosuppressive treatments to reduce inflammation and morbidity. Since 2021 EUGOGO lists Mycophenolate-sodium (MPS) as first-line-treatment, which lead to a change in ...
Julius Sander, Karim Al-Ghazzawi, Nikolaos Bechrakis, Ying Chen, Inga Neumann, Anja Eckstein, Michael Oeverhaus   +6 more
doaj   +1 more source

ÜÇÜNCÜ BASAMAK REFERANS MERKEZİNE BAŞVURAN TİROİD ORBİTOPATİ OLGULARINDA KLİNİK BULGULAR VE TEDAVİ STRATEJİLERİ

, 2008
Graves oftalmopatide (GO) izlenen semptom, klinik bulgu ve ölçülen parametrelerdeki çeşitlilik, olgularda tedavi ve takip zorluklarına yol açmaktadır. 2003 yılında EUGOGO tarafından GO olgularının değerlendirilmesinde standardizasyonu sağlamak amacıyla ...
MİNE ÖZTÜRK KURTULMUŞOĞLU
core   +2 more sources

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey

, 2007
Background: This study was performed to determine clinical features of dysthyroid optic neuropathy ( DON) across Europe. Methods: Forty seven patients with DON presented to seven European centres during one year.
MARINO', MICHELE, WIERSINGA, W. M., PINCHERA, ALDO, PITZ, S., NEOH, C., SARTINI, M. S., BOBORIDIS, K., KAHALY, G., PERROS, P., NARDI, MARCO, KRASSAS, G., MCKEAG, D., DICKINSON, . A. J, MARCOCCI, CLAUDIO, LANE, C., LAZARUS, J. H., MOURITS, M. P., BALDESCHI, LELIO, HULLO, A. I., PRUMMEL, M. F., ORGIAZZI, J., EUROPEAN GROUP ON GRAVES' ORBITOPATHY EUGOGO   +21 more
core   +1 more source

The results of surgical treatment to correct eyelid retraction with blepharotomy - preliminary report [PDF]

The study presents early results of the surgical treatment of patients with fixed upper eyelid retraction exceeding 1 mm as a complication of Graves’ disease, trauma, or high myopia.
Różycki, Radosław, Ulaszewska, Katarzyna, Nesterowicz, Piotr, Różycka, Katarzyna, Chamernik, Alan, Różycka, Małgorzata   +5 more
core   +1 more source

The Pathogenesis and Clinical Spectrum of Graves’ Orbitopathy

, 2019
Az endocrin ophthalmopathia autoimmun gyulladásos megbetegedés, amely főleg a szemkörnyéki szöveteket érinti. A betegek életminőségét jelentősen befolyásolják a tünetek.
Horváth, Fanni
core  

Yeni Tanı Graves Hastalarında Oftalmopati: İlk Tanıda Klinik-Ortoptik Özellikler ve Klinik Bulguların Manyetik Rezonans Görüntüleme Bulguları Ile Korelasyonu

, 2014
Ophthalmopathy at Newly Diagnosed Graves Patients: Clinical-Orthoptical Features at First Diagnosis and Correlations of Clinical Findings with Magnetic Resonance Image Findings, Hacettepe University Medical Faculty, Ophthalmology Department, Expertise ...
Çevik, Yakup
core  

Management of Thyroid Eye Disease: A Comparison Between Three Recent Clinical Guidelines. [PDF]

Ophthalmol Ther
Lei C, Jin J, Li R, Yip CC, Chong KKL, Smith TJ, Sun J, Zhou H.   +7 more
europepmc   +1 more source

Reactivation after total thyroidectomy? A thyroid eye disease case that challenges established clinical paradigms. [PDF]

Endocrinol Diabetes Metab Case Rep
Niño Alarcón A, Henao DC, Rojas L, Gomez AM, Ortiz Martínez Y.   +4 more
europepmc   +1 more source